Top 25 corporate institutions in cancer research
The table shows the top 25 corporate institutions ranked by their article share (Share) in cancer research from January 2015 to August 2019. Also listed are each institution's number of cancer articles (Count) from January 2015 to August 2019, and percentage of internationally collaborative articles in cancer research (International articles %) over the period.
* Click on column headers to sort
| 1 | F. Hoffmann-La Roche AG | Switzerland | 78.05 | 154 | 51.9% |
| 2 | Novartis International AG | Switzerland | 52.11 | 139 | 56.8% |
| 3 | AstraZeneca plc | United Kingdom (UK) | 32.96 | 115 | 72.2% |
| 4 | Pfizer Inc. | United States of America (USA) | 16.64 | 39 | 46.2% |
| 5 | GlaxoSmithKline plc. (GSK) | United Kingdom (UK) | 13.22 | 50 | 72.0% |
| 6 | Merck & Co., Inc. | United States of America (USA) | 13.12 | 39 | 46.2% |
| 7 | Takeda Pharmaceutical Company Limited | Japan | 11.37 | 20 | 30.0% |
| 8 | Bristol-Myers Squibb (BMS) | United States of America (USA) | 10.12 | 37 | 51.4% |
| 9 | Amgen Inc. | United States of America (USA) | 10.12 | 39 | 84.6% |
| 10 | Formosa Plastics Group | Taiwan | 9.30 | 49 | 65.3% |
| 11 | AbbVie Inc. | United States of America (USA) | 9.13 | 32 | 59.4% |
| 12 | Eli Lilly and Company | United States of America (USA) | 8.16 | 26 | 61.5% |
| 13 | Cancer Center, The Wistar Institute | United States of America (USA) | 7.93 | 24 | 45.8% |
| 14 | Johnson & Johnson | United States of America (USA) | 7.10 | 32 | 65.6% |
| 15 | Bayer AG | Germany | 6.75 | 24 | 79.2% |
| 16 | Regeneron Pharmaceuticals, Inc. | United States of America (USA) | 6.02 | 11 | 27.3% |
| 17 | BGI | China | 5.91 | 24 | 83.3% |
| 18 | H3 Biomedicine Inc. | United States of America (USA) | 5.63 | 15 | 73.3% |
| 19 | C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim) | Germany | 5.49 | 21 | 90.5% |
| 20 | Foundation Medicine, Inc. | United States of America (USA) | 4.75 | 17 | 47.1% |
| 21 | Sanofi | France | 4.51 | 20 | 80.0% |
| 22 | Merck KGaA | Germany | 4.17 | 16 | 68.8% |
| 23 | Constellation Pharmaceuticals, Inc. | United States of America (USA) | 4.11 | 8 | 12.5% |
| 24 | Alphabet Inc. | United States of America (USA) | 4.09 | 8 | 0.0% |
| 25 | Thermo Fisher Scientific Inc. | United States of America (USA) | 3.58 | 21 | 57.1% |